Follow The Filings

WAT Waters

Health Care, filed as WATERS CORP (COM), Equity As of 2026 Q2 among managers we track Quote on Google Finance, opens in a new tab

Bought by 1 manager in 2026 Q2, sold by 4

  • 8 Owners
  • #125
  • Max 6.3%
  • Master 0.13%
  • $2.2B
  • 1 add 4 reduce 3 small

In 2026 Q2, 1 manager added and 4 trimmed.

Who owns this now

Largest portfolio weights among holders, up to 6.3% (Terry Smith, Fundsmith). Not free-float ownership.

  1. Terry Smith Reduce 6.3%
  2. Andreas Halvorsen Add 1.8%
  3. Ako Capital Reduce 1.8%
  4. First Pacific Advisors Add 1.2%
  5. First Eagle Investment Manage... Reduce 0.84%
  6. Jensen Investment Management Reduce 0.35%

Who owns WAT

Sorted by value, long equity only, as of 2026 Q2.

History
Terry Smith, Fundsmith 6.3%, was 7.5% Reduce −29.2% 2,273,632 $853M History
Andreas Halvorsen, Viking Global Investors 1.8%, was 1.1% Add +32.3% 1,662,140 $623M History
First Eagle Investment Management 0.84% Reduce −15.2% 1,335,108 $501M History
First Pacific Advisors 1.2%, was 1.1% Small add +0.3% 268,164 $101M History
Ako Capital 1.8%, was 4.8% Reduce −75.1% 203,356 $76M History
Jensen Investment Management 0.35% Small trim −0.5% 38,566 $14M History
Bill Nygren / Oakmark, Harris Associates L P 0.01%, was 0.12% Reduce −93.6% 18,413 $6.9M History
Mairs & Power <0.01% Small add +0.1% 959 $360K History

8 current, options excluded

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by WAT's executives, directors and 10% owners in the last 12 months, from their Form 4s

All WAT insider trades
  • $451K bought by 2 insiders
  • $1.4M sold by 1 insider outside a trading plan
  • None no planned (10b5-1) sales
  1. Christopher A Kuebler Director
    Sale
    $1.4M 3,626 shares at $397.94 17% of stake
    Traded Aug 6 Filed Aug 7
    ↗
  2. Wei Jiang Director
    Buy
    $145K 500 shares at $289.46 +17% to stake
    Traded Mar 16 Filed Mar 18
    ↗
  3. Richard H Fearon Director
    Buy
    $306K 1,000 shares at $306.34 +43% to stake
    Traded Mar 6 Filed Mar 10
    ↗

Also filed in the last 12 months, not counted as buying or selling: 34 stock grants, 11 share withholdings for taxes, and 2 option exercises.

Congress

8 members of Congress traded WAT in the last three years: 10 buys and 7 sales. 4 members listed it in 2025 annual reports.

All Congress trades
  1. Kevin Hern R-OK-1Joint Sell $1K–$15K Aug 13 filed Sep 1
  2. Thomas H. Kean, Jr. R-NJ-7 Partial sale $1K–$15K Mar 10 filed Apr 13
  3. Gilbert Ray Cisneros, Jr. D-CA-31 Buy $1K–$15K Mar 18 filed Apr 7
  4. Thomas H. Kean, Jr. R-NJ-7 Partial sale $1K–$15K Feb 13 filed Mar 18
  5. Kevin Hern R-OK-1Joint Exchange $1K–$15K Feb 9 filed Mar 6
  6. Debbie Dingell D-MI-6 Exchange $1K–$15K Feb 10 filed Feb 23

SEC filings

Recent issuer filings from EDGAR, 16 shown.

Filed Form Detail Links
8-K 5.02,8.01 Filing Doc
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 5.07 Filing Doc
SCHEDULE 13G/A — Filing Doc
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13G/A — Filing Doc
DEF 14A Filing Doc
DEFA14A Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 1.01,2.03,8.01,9.01 Filing Doc
424B2 Filing Doc
8-K 8.01,9.01 Filing Doc
424B2 Filing Doc

Source: SEC EDGAR submissions, updated 13 days ago. All on EDGAR

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Revenue $2.96B $2.96B $3.17B
Gross profit * $1.76B $1.76B $1.88B
Gross margin * 59.6% 59.4% 59.3%
Net income — $637.83M $642.63M
Net margin * — 21.6% 20.3%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $1.75B $1.67B $2.15B
Total non-current assets * $2.87B $2.88B $2.93B
Total assets $4.63B $4.55B $5.08B
Total current liabilities $0.79B $0.79B $1.24B
Total non-current liabilities $2.69B $1.94B $1.28B
Total equity $1.15B $1.83B $2.56B

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations $602.81M $762.12M $652.56M
Cash from investing -$1.44B -$0.144B -$0.152B
Cash from financing $754.95M -$696.68M -$237.2M
Net change in cash -$85.45M -$70.66M $262.48M

Source: SEC companyfacts (US-GAAP 10-K). A * marks a computed figure, not a single XBRL tag. Fiscal years are as the issuer labels them. Follow The Filings does not adjust or audit these figures.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.